explore -WSS

explore

author：explore 2025-09-30 22:28:22 - browse：8

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Are infertility treatments 'essential' during the Covid

knowledge

WSS

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Telehealth startups are trying to fill the menopause care vacuum

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Cybersecurity threat forces Lurie Children's to take systems offline

Judge denies Trump's request for new trial in E. Jean Carroll case

entertainment

explore

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Juul spent big to court Black leaders to promote its e

Bright Health sells Medicare Advantage business to Molina

After a decade, new Gardasil ad campaign gets it (mostly) right

Guidelines to prevent youth baseball injuries need more muscle

FDA drug safety: Singulair case shows systemic surveillance flaws

Affirmative action in medical school literally saved lives

Vertex non

In age of alternative facts, a scholarly course on calling out crap

Apple Vision Pro: A first look at health apps on the new VR headset

Wikipedia

Caribou posts encouraging results on off

Stanford president’s abrupt resignation sparks debate

Caribou posts encouraging results on off

Cognito secures funding to test medical device for Alzheimer's

General Catalyst, Summa Health deal will turn on physician buy

How a Boston hospital is priming medical residents to use GPT

explore

knowledge

focus

hotspot